Barely Significant
← all excerpts

Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trials.

Cancer Sci · 2018 · PMC5765308 · PMID 29114963

Europe PMCDOI
1
hedged sentence
0.0670
closest p · 1.3× alpha
0.0670
boldest claim

The sentences

marginally significantP = .067so close (0.05 < p ≤ 0.1)
No associations between the dose group (or average RDI) and response rate were found in the multivariate logistic regression analysis (Table S4 ), but the difference in the response rate between the 2 groups (ie, 10.9% of RP2D group vs 1.9% of OLLD group) was shown to be marginally significant by Fisher's exact test ( P = .067).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.